Azacitidine

Overview

Azacitidine is a chemical compound used primarily in the treatment of myelodysplastic syndromes. It is a pyrimidine nucleoside analogue of cytidine with antineoplastic activity.

API suppliers (9)

Suppliers of Azacitidine backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• SHANDONG XINHUA PHARMACEUTICAL CO LTDChina1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• Hetero Labs LimitedIndia1 active DMF
• SCINOPHARM TAIWAN LTD1 active DMF
• SCINOPHARM TAIWAN LTD1 active DMF
• CHEMWERTH INC1 active DMF
• Dr. Reddy's Laboratories Ltd.India1 active DMF
• EUTICALS SPAItaly
• MYLAN LABORATORIES LTD

Patent & exclusivity (US)

Per the FDA Orange Book (16 approved US products), the latest listed US patent on Azacitidine expires 2 Jun 2030 and exclusivity 19 May 2029. Generic API sourcing typically opens up once these lapse.

Therapeutic areas